Ruth E. Gimeno
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Adipose Tissue and Metabolism, Peroxisome Proliferator-Activated Receptors, Lipid metabolism and biosynthesis, Adipokines, Inflammation, and Metabolic Diseases, Pancreatic function and diabetes
Most-Cited Works
- → LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept(2018)782 cited
- → Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial(2018)774 cited
- → Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages(2007)723 cited
- → The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL(2017)634 cited
- → Cloning and Characterization of an Uncoupling Protein Homolog: A Potential Molecular Mediator of Human Thermogenesis(1997)480 cited
- → Identification of the Major Intestinal Fatty Acid Transport Protein(1999)410 cited
- → Molecular, biochemical and functional characterizations of C1q/TNF family members: adipose-tissue-selective expression patterns, regulation by PPAR-γ agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functions(2008)368 cited
- → Transport Function and Regulation of Mitochondrial Uncoupling Proteins 2 and 3(1999)325 cited
- → Expression, regulation, and triglyceride hydrolase activity of Adiponutrin family members(2005)298 cited
- → Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin(2008)281 cited